- Home
- TRDA vs HIFS Comparison
TRDA vs HIFS Comparison
Compare TRDA & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- HIFS
- Stock Information
- Founded
- TRDA 2016
- HIFS 1834
- Country
- TRDA United States
- HIFS United States
- Employees
- TRDA N/A
- HIFS N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- HIFS Major Banks
- Sector
- TRDA Health Care
- HIFS Finance
- Exchange
- TRDA Nasdaq
- HIFS Nasdaq
- Market Cap
- TRDA 336.6M
- HIFS 485.3M
- IPO Year
- TRDA 2021
- HIFS N/A
- Fundamental
- Price
- TRDA $8.38
- HIFS $259.25
- Analyst Decision
- TRDA Strong Buy
- HIFS
- Analyst Count
- TRDA 3
- HIFS 0
- Target Price
- TRDA $25.67
- HIFS N/A
- AVG Volume (30 Days)
- TRDA 139.5K
- HIFS 11.4K
- Earning Date
- TRDA 05-08-2025
- HIFS 04-11-2025
- Dividend Yield
- TRDA N/A
- HIFS 0.97%
- EPS Growth
- TRDA N/A
- HIFS 14.93
- EPS
- TRDA 0.61
- HIFS 12.96
- Revenue
- TRDA $172,220,000.00
- HIFS $67,590,000.00
- Revenue This Year
- TRDA N/A
- HIFS N/A
- Revenue Next Year
- TRDA N/A
- HIFS N/A
- P/E Ratio
- TRDA $14.69
- HIFS $20.01
- Revenue Growth
- TRDA 5.74
- HIFS 12.43
- 52 Week Low
- TRDA $7.10
- HIFS $164.00
- 52 Week High
- TRDA $21.79
- HIFS $300.00
- Technical
- Relative Strength Index (RSI)
- TRDA 43.04
- HIFS 61.75
- Support Level
- TRDA $7.71
- HIFS $250.58
- Resistance Level
- TRDA $9.46
- HIFS $254.99
- Average True Range (ATR)
- TRDA 0.60
- HIFS 4.96
- MACD
- TRDA 0.05
- HIFS 1.29
- Stochastic Oscillator
- TRDA 38.29
- HIFS 94.08
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.